ClinicalTrials.gov record
Completed Phase 2 Interventional

Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer

ClinicalTrials.gov ID: NCT00021333

Public ClinicalTrials.gov record NCT00021333. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 4:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Evaluation Of Paclitaxel And Cisplatin In Combination With Split Course Hyperfractionated Radiation Therapy And Granulocyte-Colony Stimulating Factor In Previously Irradiated Patients With Locally Recurrent Carcinoma Of The Head And Neck, And Lung

Study identification

NCT ID
NCT00021333
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Fox Chase Cancer Center
Other
Enrollment
29 participants

Conditions and interventions

Interventions

  • cisplatin Drug
  • filgrastim Biological
  • paclitaxel Drug
  • radiation therapy Radiation

Drug · Biological · Radiation

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 1999
Primary completion
Mar 31, 2006
Completion
Apr 30, 2008
Last update posted
Apr 16, 2013

1999 – 2008

United States locations

U.S. sites
18
U.S. states
2
U.S. cities
18
Facility City State ZIP Site status
Hunterdon Regional Cancer Center Flemington New Jersey 08822
Kimball Medical Center Lakewood New Jersey 08701
South Jersey Regional Cancer Center Millville New Jersey 08332
Fox Chase Cancer Center at Virtua Memorial Hospital Burlington County Mount Holly New Jersey 08060
Riverview Medical Center - Booker Cancer Center Red Bank New Jersey 07701
Community Medical Center Toms River New Jersey 08755
St. Francis Medical Center Trenton New Jersey 08629
Bon Secours-Holy Family Health System Altoona Pennsylvania 16602
Delaware County Memorial Hospital Drexel Hill Pennsylvania 19026
Pinnacle Health Hospitals Harrisburg Pennsylvania 17105-8700
Conemaugh Memorial Hospital Johnstown Pennsylvania 15905
Saint Mary Regional Center Langhorne Pennsylvania 19047
Central Montgomery Medical Center Lansdale Pennsylvania 19446-1200
Paoli Memorial Hospital Paoli Pennsylvania 19301-1792
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
Pottstown Memorial Regional Cancer Center Pottstown Pennsylvania 19464
Reading Hospital and Medical Center Reading Pennsylvania 19612-6052
Southern Chester County Medical Center West Grove Pennsylvania 19390

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00021333, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 16, 2013 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00021333 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →